NORTHAMPTON, MA / ACCESS Newswire / April 28, 2026 / Direct Relief and The Pfizer Foundation today announced the third cohort of the Innovation Awards in Community Health, supporting infectious ...
It was hailed as a “triumph of 21st century medicine” — a daily pill that cures a life-threatening liver disease in a matter ...
This analysis demonstrates value and innovation of direct-acting antivirals for the treatment of chronic hepatitis C in the US Kaiser Permanente health system. Objectives: Direct-acting antivirals ...
People offered hep C care on-site at their OTP were nearly four times more likely to initiate it than those given off-site ...
First patient enrolled in ECLIPSE 2 Phase 3 clinical trial evaluating the switch to the combination of tobevibart and elebsiran in patients not achieving undetectable hepatitis delta virus RNA despite ...
On Jan 5, 2026, the Acting Director of the US Centers for Disease Control and Prevention (CDC) signed a decision memorandum from the heads of the National Institutes of Health, the Centers for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results